WallStSmart

American Healthcare REIT, Inc. (AHR)vsWeyerhaeuser Company (WY)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Weyerhaeuser Company generates 190% more annual revenue ($6.87B vs $2.37B). WY leads profitability with a 5.8% profit margin vs 4.2%. WY trades at a lower P/E of 44.4x. WY earns a higher WallStSmart Score of 57/100 (C).

AHR

Hold

48

out of 100

Grade: D+

Growth: 8.7Profit: 4.5Value: 4.0Quality: 5.5
Piotroski: 3/9Altman Z: 0.95

WY

Buy

57

out of 100

Grade: C

Growth: 4.7Profit: 4.5Value: 4.0Quality: 6.0
Piotroski: 2/9Altman Z: 1.46
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for AHR.

WYSignificantly Overvalued (-28.9%)

Margin of Safety

-28.9%

Fair Value

$21.02

Current Price

$24.48

$3.46 premium

UndervaluedFair: $21.02Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AHR3 strengths · Avg: 8.7/10
EPS GrowthGrowth
306.2%10/10

Earnings expanding 306.2% YoY

Price/BookValuation
2.6x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
20.9%8/10

Revenue surging 20.9% year-over-year

WY2 strengths · Avg: 9.0/10
EPS GrowthGrowth
96.6%10/10

Earnings expanding 96.6% YoY

Price/BookValuation
1.9x8/10

Reasonable price relative to book value

Areas to Watch

AHR4 concerns · Avg: 2.8/10
Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Profit MarginProfitability
4.2%3/10

4.2% margin — thin

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

P/E RatioValuation
78.6x2/10

Premium valuation, high expectations priced in

WY4 concerns · Avg: 2.8/10
Return on EquityProfitability
4.2%3/10

ROE of 4.2% — below average capital efficiency

Profit MarginProfitability
5.8%3/10

5.8% margin — thin

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

P/E RatioValuation
44.4x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : AHR

The strongest argument for AHR centers on EPS Growth, Price/Book, Revenue Growth. Revenue growth of 20.9% demonstrates continued momentum.

Bull Case : WY

The strongest argument for WY centers on EPS Growth, Price/Book. PEG of 1.35 suggests the stock is reasonably priced for its growth.

Bear Case : AHR

The primary concerns for AHR are Return on Equity, Profit Margin, Piotroski F-Score. A P/E of 78.6x leaves little room for execution misses. Thin 4.2% margins leave little buffer for downturns.

Bear Case : WY

The primary concerns for WY are Return on Equity, Profit Margin, Piotroski F-Score. A P/E of 44.4x leaves little room for execution misses.

Key Dynamics to Monitor

AHR profiles as a growth stock while WY is a value play — different risk/reward profiles.

AHR carries more volatility with a beta of 0.94 — expect wider price swings.

AHR is growing revenue faster at 20.9% — sustainability is the question.

AHR generates stronger free cash flow (50M), providing more financial flexibility.

Bottom Line

WY scores higher overall (57/100 vs 48/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

American Healthcare REIT, Inc.

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

American Healthcare REIT, Inc. is a prominent real estate investment trust (REIT) focused on acquiring and managing a diversified portfolio of premium healthcare facilities across the United States, including senior housing, skilled nursing, and medical office properties. The company partners with leading operators in the healthcare sector to provide stable cash flows and long-term growth, all while enhancing the quality of care for residents and patients. As the healthcare real estate market continues to grow, American Healthcare REIT presents an attractive investment proposition for institutional investors seeking exposure to a vital and resilient segment of the economy.

Visit Website →

Weyerhaeuser Company

REAL ESTATE · REIT - SPECIALTY · USA

Weyerhaeuser Company is an American timberland company which owns nearly 12,400,000 acres of timberlands in the U.S. and manages an additional 14,000,000 acres timberlands under long-term licenses in Canada. The company also manufactures wood products. Weyerhaeuser is a real estate investment trust.

Visit Website →

Want to dig deeper into these stocks?